Literature DB >> 7750208

Acquisition and enhanced expression of the metastatic phenotype following transfections of genomic mouse tumor DNA containing human SCLC gene sequences.

C C Cate1, D R Belloni, M Marin-Padilla.   

Abstract

Previous primary and secondary co-transfections of genomic DNA from a metastatic human small cell lung cancer cell line into NIH/3T3 cells resulted in a murine fibrosarcoma cell line (Tx93B) that produced frequent spontaneous lung metastases in subcutaneously injected tumor-bearing nude mice. In order to transfer the acquired metastatic behavior to additional cell lines that could then be tested in syngeneic immunocompetent animals, DNA from Tx93B cells was transfected without additional neo gene into Balb/c embryo fibroblasts, which led to the isolation of a tertiary transfectant cell line (D3) of low spontaneous metastatic potential in normal Balb/c mice. Subsequent cell lines established serially from lung metastases in mice injected with D3, and metastatic descendants of D3 (all selected for the original neo marker in G-418), resulted in three generations of metastatically variant cell lines capable of causing pulmonary metastases in 11.1%, 54.6%, and 89.5%, respectively, of subcutaneously injected animals, and in 100% of normal mice injected intraperitoneally. There was no apparent ras-family oncogene participation in the metastatic behavior of either of the two DNA donor cell lines or in the metastatically variant tertiary transfectants. Gelatin zymography indicated that the secretion of gelatinolytic enzymes in vitro by the variant cell lines was inversely proportional to their metastatic capability. Human Alu repeat gene sequences detected in the metastatic variants suggested that co-transfected metastasis-associated genes present in the original human DNA donor cell may have contributed to acquisition of the metastatic phenotype by the tertiary transfectant cell lines. The increase in metastatic potential observed in successive generations of the D3-derived tumor cell lines, further suggested that selection for cells having increased metastatic capability had occurred during passage in vivo accounting for the phenotypic change. Because of their common origin and progressively metastatic nature these cell lines may prove useful in the identification of metastasis-associated genes accessible through the use of differential expression cloning strategies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7750208     DOI: 10.1007/BF00132209

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  36 in total

1.  Metastatic phenotype in murine cells transfected with human DNA.

Authors:  J Glenn; D McDonald; R L Horetsky; F M Sexton
Journal:  J Surg Res       Date:  1988-04       Impact factor: 2.192

2.  Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells.

Authors:  S E Egan; G A McClarty; L Jarolim; J A Wright; I Spiro; G Hager; A H Greenberg
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

3.  Clonal selection within metastatic SP1 mouse mammary tumors is independent of metastatic potential.

Authors:  M Samiei; C G Waghorne
Journal:  Int J Cancer       Date:  1991-03-12       Impact factor: 7.396

4.  Different malignant phenotypes induced in a stable, subdiploid, benign epithelial clone by DNA transfection.

Authors:  J R Gibbins; T R Nicholson; R J Vozab; B Ying; K R Messerle
Journal:  Anticancer Res       Date:  1991 Jan-Feb       Impact factor: 2.480

5.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Authors:  Z Zou; A Anisowicz; M J Hendrix; A Thor; M Neveu; S Sheng; K Rafidi; E Seftor; R Sager
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

6.  Transfection of metastatic capability with total genomic DNA from human and mouse metastatic tumour cell lines.

Authors:  A J Hayle; D L Darling; A R Taylor; D Tarin
Journal:  Differentiation       Date:  1993-10       Impact factor: 3.880

7.  Selective enhancement of metastatic capacity in mouse bladder carcinoma cells after transfection with DNA from liver metastases of human colon carcinoma.

Authors:  A Radler-Pohl; J Pohl; V Schirrmacher
Journal:  Int J Cancer       Date:  1988-06-15       Impact factor: 7.396

8.  Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations.

Authors:  C Waghorne; M Thomas; A Lagarde; R S Kerbel; M L Breitman
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

9.  Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase.

Authors:  H Kataoka; R DeCastro; S Zucker; C Biswas
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

10.  Correlation between Ha-ras gene amplification and spontaneous metastasis in NIH 3T3 cells transfected with genomic DNA from human skin cancers.

Authors:  H N Ananthaswamy; J E Price; M A Tainsky; L H Goldberg; E S Bales
Journal:  Clin Exp Metastasis       Date:  1989 May-Jun       Impact factor: 5.150

View more
  2 in total

1.  Generation of metastatic variants by transfection of a rat non-metastatic epithelial cell line with genomic DNA from rat prostatic carcinoma cells.

Authors:  Y Ke; C Beesley; P Smith; R Barraclough; P Rudland; C S Foster
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

2.  Experimental research of host macrophage canceration induced by glioma stem progenitor cells.

Authors:  Aidong Wang; Xingliang Dai; Baoqian Cui; Xifeng Fei; Yanming Chen; Jinshi Zhang; Quanbin Zhang; Yaodong Zhao; Zhimin Wang; Hua Chen; Qing Lan; Jun Dong; Qiang Huang
Journal:  Mol Med Rep       Date:  2014-12-02       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.